Partner Dan Shores was interviewed by Charlotte Barker of Vaccine Insights for the Viewpoint article titled "Navigating the mRNA-LNP patent labyrinth: advice for developers" published on November 7, 2024.
Dan and Ms. Barker, Commissioning Editor, spoke on October 3, 2024, about intellectual property challenges in the mRNA-lipid nanoparticle space and potential patent strategies for emerging biotech companies in the field. This article has been written based on the interview.
Launched in May 2022, Vaccine Insights is a peer-reviewed, open-access journal with a translational focus. Bringing together leading experts from pharma, biotech, academia, and other key stakeholders, critical issues are addressed and the latest developments are put into context – sifting through the deluge of data to reveal valuable insights into where the field is heading. Guided by an expert advisory board, the journal covers the most important advances in vaccine development and manufacturing across all disease areas, for both prophylactic and therapeutic vaccines. Vaccine Insights helps readers stay up to date with this rapidly evolving field via accessible and timely reviews, commentary and analysis, original research articles, roundtable discussions, webinars, and podcasts.
Click here to access Dan's article, "Navigating the mRNA-LNP patent labyrinth: advice for developers." Note you will need to enter required information but no payment is required.
